Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
Atilla SoranS OzbasB OzcinarA IsikL DoganK SenolA DagH KaranlikO AytacG Karadeniz CakmakK DalciM DoganY A SezerS GokgozE OzyarE Sezginnull nullPublished in: Annals of surgical oncology (2022)
Metastasis-directed interventions have reduced the risk of death for patients with limited lung/liver metastases who are amenable to interventions after completion of primary cancer treatment. For a select group of patients, such as those with luminal A/B or HER2-neu+ breast cancer who are younger than 55 years with limited metastases to the lung and liver or an MDFI longer than 24 months, surgical or ablative therapy for metastases should be considered and discussed on tumor boards.